Newsroom

Press Release - All

• 22 Feb 2021
  Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
• 18 Feb 2021
  Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
• 18 Feb 2021
  Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
• 17 Feb 2021
  Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
• 16 Feb 2021
  Agilent Reports First-Quarter Fiscal Year 2021 Financial Results
• 08 Feb 2021
  Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
• 01 Feb 2021
  Agilent Wins Trade Secret and Patent Infringement Litigation
• 26 Jan 2021
  Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
• 25 Jan 2021
  Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines
• 15 Jan 2021
  Agilent Names Allison Ballmer Senior Vice President of Corporate Development